Estee Lauder’s (EL) Q1 Earnings, Sales Beat Estimates

Zacks

Estee Lauder Companies, Inc. EL is one of the world's leading manufacturers and marketers of quality skin care, makeup and fragrance and hair care products.

Estee Lauder has been posting better-than-expected results over the past several quarters backed by organic sales growth, product innovation and cost savings measures. Although these positive trends have resulted in earnings growth, currency headwinds have led to declining export volume for the cosmetics company over the past few quarters. Due to this, investors are eagerly awaiting EL’s earnings report.

There has been hardly any change in the earnings estimate for EL over the past 30 days’ period. Further, EL does have a decent history when it comes to recent earnings reports as the stock has beaten estimates in all of the previous last four quarters making for an average surprise of 27.98%.

Currently, EL has a Zacks Rank #3 (Hold), but that could definitely change following Estee Lauder’s earnings report which was just released. We have highlighted some of the key stats from this just-revealed announcement below:

Earnings:EL posted earnings of 82 cents, much better than our consensus of 69 cents. Investors should note that these figures take out stock option expenses.

Revenue:EL posted revenues of $283. billion. This beats our consensus estimate of $2.79 billion.

Key Stats to Note:Estee Lauder’s earnings and sales increased 38% and 15%, respectively, on a constant currency basis, after adjusting for the accelerated sales orders. In fiscal 2016, the company expects constant currency net sales growth of 8% to 10%.

Stock Price: Inactive in pre-market trading.

Check back later for our full write up on this EL earnings report later!

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research

Be the first to comment

Leave a Reply